Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease.

MLA

Clayton, Nicholas P., et al. “Antisense Oligonucleotide-Mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease.” Molecular Therapy. Nucleic Acids, vol. 3, Oct. 2014, p. e206. EBSCOhost, https://doi.org/10.1038/mtna.2014.57.

APA

Clayton, N. P., Nelson, C. A., Weeden, T., Taylor, K. M., Moreland, R. J., Scheule, R. K., Phillips, L., Leger, A. J., Cheng, S. H., & Wentworth, B. M. (2014). Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease. Molecular Therapy. Nucleic Acids, 3, e206. https://doi.org/10.1038/mtna.2014.57

Chicago

Clayton, Nicholas P, Carol A Nelson, Timothy Weeden, Kristin M Taylor, Rodney J Moreland, Ronald K Scheule, Lucy Phillips, Andrew J Leger, Seng H Cheng, and Bruce M Wentworth. 2014. “Antisense Oligonucleotide-Mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease.” Molecular Therapy. Nucleic Acids 3 (October): e206. doi:10.1038/mtna.2014.57.